全文获取类型
收费全文 | 5093篇 |
免费 | 247篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 86篇 |
儿科学 | 327篇 |
妇产科学 | 66篇 |
基础医学 | 697篇 |
口腔科学 | 81篇 |
临床医学 | 296篇 |
内科学 | 890篇 |
皮肤病学 | 100篇 |
神经病学 | 316篇 |
特种医学 | 90篇 |
外科学 | 706篇 |
综合类 | 178篇 |
一般理论 | 4篇 |
预防医学 | 391篇 |
眼科学 | 97篇 |
药学 | 616篇 |
中国医学 | 32篇 |
肿瘤学 | 374篇 |
出版年
2023年 | 31篇 |
2022年 | 41篇 |
2021年 | 171篇 |
2020年 | 116篇 |
2019年 | 142篇 |
2018年 | 157篇 |
2017年 | 103篇 |
2016年 | 141篇 |
2015年 | 181篇 |
2014年 | 219篇 |
2013年 | 240篇 |
2012年 | 398篇 |
2011年 | 391篇 |
2010年 | 211篇 |
2009年 | 164篇 |
2008年 | 299篇 |
2007年 | 266篇 |
2006年 | 283篇 |
2005年 | 215篇 |
2004年 | 212篇 |
2003年 | 178篇 |
2002年 | 132篇 |
2001年 | 111篇 |
2000年 | 108篇 |
1999年 | 97篇 |
1998年 | 45篇 |
1997年 | 29篇 |
1996年 | 21篇 |
1995年 | 20篇 |
1994年 | 18篇 |
1993年 | 30篇 |
1992年 | 59篇 |
1991年 | 37篇 |
1990年 | 34篇 |
1989年 | 60篇 |
1988年 | 45篇 |
1987年 | 22篇 |
1986年 | 30篇 |
1985年 | 29篇 |
1984年 | 24篇 |
1983年 | 37篇 |
1981年 | 13篇 |
1980年 | 18篇 |
1979年 | 23篇 |
1978年 | 13篇 |
1975年 | 11篇 |
1973年 | 18篇 |
1972年 | 13篇 |
1971年 | 12篇 |
1970年 | 13篇 |
排序方式: 共有5347条查询结果,搜索用时 31 毫秒
1.
2.
Joseph F. Levy Rahul Khairnar Alexander V. Louie Timothy N. Showalter C. Daniel Mullins Mark V. Mishra 《Practical radiation oncology》2019,9(2):e172-e179
Purpose
A hydrogel rectal spacer (HRS) is a medical device that is approved by the U.S. Food and Drug Administration to increase the separation between the prostate and rectum. We conducted a cost-effectiveness analysis of HRS use for reduction in radiation therapy (RT) toxicities in patients with prostate cancer (PC) undergoing external beam RT (EBRT).Methods and Materials
A multistate Markov model was constructed from the U.S. payer perspective to examine the cost-effectiveness of HRS in men with localized PC receiving EBRT (EBRT alone vs EBRT + HRS). The subgroups analyzed included site of HRS placement (hospital outpatient, physician office, ambulatory surgery center) and proportion of patients with good baseline erectile function (EF). Data on EF, gastrointestinal and genitourinary toxicities incidence, and potential risks associated with HRS implantation were obtained from a recently published randomized clinical trial. Health utilities and costs were derived from the literature and the 2018 Physician Fee Schedule and were discounted 3% annually. Quality-adjusted life years (QALYs) and costs were modeled for a 5-year period from receipt of RT. Probabilistic sensitivity analysis and value-based threshold analyses were conducted.Results
The per-patient 5-year incremental cost for spacers administered in a hospital outpatient setting was $3578, and the incremental effectiveness was 0.0371 QALYs. The incremental cost-effectiveness ratio was $96,440/QALY for patients with PC undergoing HRS insertion in a hospital and $39,286/QALY for patients undergoing HRS insertion in an ambulatory facility. For men with good baseline EF, the incremental cost-effectiveness ratio was $35,548/QALY and $9627/QALY in hospital outpatient and ambulatory facility settings, respectively.Conclusions
Based on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision-making. 相似文献3.
4.
Ashok Garg Deepak Agrawal Deepika Mishra Gyarsi Lal Sharma 《Echocardiography (Mount Kisco, N.Y.)》2019,36(7):1421-1422
Raghib syndrome is a rare developmental complex consisting of termination of the left superior vena cava in the left atrium, absence of the coronary sinus, and an atrial septal defect commonly located at the posterior‐inferior angle of the atrial septum. This complex was considered unique to Raghib syndrome; however, cases with a normal atrial septum have been reported where the orifice of the unroofed coronary sinus functions as the inter‐atrial communication. Our patient demonstrated an isolated persistent left superior vena cava draining into the left atrium through unroofed coronary sinus and presence of ostium primum atrial septal defect. 相似文献
5.
6.
Aasha I. Hoogland Hailey W. Bulls Brian D. Gonzalez Brent J. Small Lianqi Liu Joseph Pidala Heather S.L. Jim Asmita Mishra 《Journal of pain and symptom management》2019,57(5):952-960.e1
Context
Quality of life (QoL) is increasingly recognized as an important outcome of cancer treatment. Previous studies have examined clinical predictors of QoL, but with the increasing prevalence of wearable sensors that monitor sleep and activity patterns, further investigation into whether these behaviors are predictive of post-treatment QoL is now feasible. Among patients receiving aggressive cancer treatment such as hematopoietic cell transplantation (HCT), analysis of circadian rhythms (24-hour patterns of sleep and activity) via wearable sensors is limited.Objective
To evaluate the relationship between overall QoL and circadian rhythms in patients receiving allogeneic HCT.Methods
Patients wore an ActiGraph GT3X (Pensacola, FL) activity monitor for at least 72 hours before the initiation of conditioning chemotherapy and transplantation and completed a QoL (Functional Assessment of Cancer Therapy-General [FACT-G]) assessment. QoL assessments were also completed 1, 3, and 6 months after HCT.Results
Patients (n = 45, M age = 55) were mostly male (66%) with a total FACT-G score of 80.96 (SD = 16.05) before HCT. Mixed models revealed robust cross-sectional associations between overall QoL and multiple circadian rhythmicity parameters, including durations of high physical activity, overall circadian rhythmicity, and earlier starts of daily activity (P's < .01). Recovery of QoL after transplant was predicted by longer pre-transplant durations of high physical activity (P = .04) and earlier evening retirement (P = .04).Conclusion
Our findings suggest that wearable sensor information is a promising method of predicting recovery of QoL after HCT. Additional studies are needed to confirm these findings in a larger sample. 相似文献7.
Bahare Salehi Dmitry A. Konovalov Pascaline Fru Petrina Kapewangolo Gregorio Peron Mileski S. Ksenija Susana M. Cardoso Olivia R. Pereira Manisha Nigam Silvana Nicola Giuseppe Pignata Simona Rapposelli Simona Sestito Nanjangud V. Anil Kumar María de la Luz Cdiz‐Gurrea Antonio Segura‐Carretero Abhay P. Mishra Mehdi Sharifi‐Rad William C. Cho Yasaman Taheri William N. Setzer Javad Sharifi‐Rad 《Phytotherapy research : PTR》2020,34(9):2140-2158
The family Arecaceae includes 181 genera and 2,600 species with a high diversity in physical characteristics. Areca plants, commonly palms, which are able to grow in nearly every type of habitat, prefer tropical and subtropical climates. The most studied species Areca catechu L. contains phytochemicals as phenolics and alkaloids with biological properties. The phenolics are mainly distributed in roots followed by fresh unripe fruits, leaves, spikes, and veins, while the contents of alkaloids are in the order of roots, fresh unripe fruits, spikes, leaves, and veins. This species has been reputed to provide health effects on the cardiovascular, respiratory, nervous, metabolic, gastrointestinal, and reproductive systems. However, in many developing countries, quid from this species has been associated with side effects, which include the destruction of the teeth, impairment of oral hygiene, bronchial asthma, or oral cancer. Despite these side effects, which are also mentioned in this work, the present review collects the main results of biological properties of the phytochemicals in A. catechu. This study emphasizes the in vitro and in vivo antioxidant, antimicrobial, anticancer, and clinical effectiveness in humans. In this sense, A. catechu have demonstrated effectiveness in several reports through in vitro and in vivo experiments on disorders such as antimicrobial, antioxidant, or anticancer. Moreover, our findings demonstrate that this species presents clinical effectiveness on neurological disorders. Hence, A. catechu extracts could be used as a bioactive ingredient for functional food, nutraceuticals, or cosmeceuticals. However, further studies, especially extensive and comprehensive clinical trials, are recommended for the use of Areca in the treatment of diseases. 相似文献
8.
9.
10.
Mishra Abhinav Rastogi Neelkamal 《Proceedings of the National Academy of Sciences, India. Section B.》2020,90(3):567-576
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences - The results show that the orb-weaver spiders, Neoscona theisi and Cyrtophora citricola, occurred in both... 相似文献